Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRIW) Interest & Investment Income (2023 - 2025)

Biofrontera has reported Interest & Investment Income over the past 3 years, most recently at -$121000.0 for Q4 2025.

  • Quarterly results put Interest & Investment Income at -$121000.0 for Q4 2025, down 202.5% from a year ago — trailing twelve months through Dec 2025 was -$453000.0 (up 77.74% YoY), and the annual figure for FY2025 was -$452000.0, up 77.79%.
  • Interest & Investment Income for Q4 2025 was -$121000.0 at Biofrontera, down from -$111000.0 in the prior quarter.
  • Over the last five years, Interest & Investment Income for BFRIW hit a ceiling of $56000.0 in Q1 2023 and a floor of -$1.4 million in Q1 2024.
  • Median Interest & Investment Income over the past 3 years was -$113000.0 (2025), compared with a mean of -$259250.0.
  • Peak annual rise in Interest & Investment Income hit 105.63% in 2024, while the deepest fall reached 2612.5% in 2024.
  • Biofrontera's Interest & Investment Income stood at -$579000.0 in 2023, then skyrocketed by 93.09% to -$40000.0 in 2024, then plummeted by 202.5% to -$121000.0 in 2025.
  • The last three reported values for Interest & Investment Income were -$121000.0 (Q4 2025), -$111000.0 (Q3 2025), and -$115000.0 (Q2 2025) per Business Quant data.